​Emily W Zantow, MD


  • Clinical Instructor

Specialty areas

  • Obstetrics and Gynecology


  • Oklahoma, 2015 - present

Board Certification

  • Board Eligible


  • MD degree, Washington University in St. Louis School of Medicine, 2015
  • Residency in Obstetrics and Gynecology, University of Oklahoma, 2015 - 2019

Areas of Clinical Interest

  • General and high-risk obstetrics
  • OB/GYN ultrasound

Research Interests

  • OB/GYN ultrasound
  • Maternal complications of pregnancy
  • Prevention of maternal morbidity and mortality


  • American College of Obstetricians and Gynecologists
  • American Institute of Ultrasound in Medicine
  • ​Society for Maternal-Fetal Medicine
  • American Medical Association

Awards/Honors (selected)

  • Resident Teaching Award for Excellence in Medical Student Education, OUHSC, 2016, 2017, 2018, 2019
  • ​Best Quality Improvement Project, OUHSC Department of OB/GYN, 2018

Publications (last five years)

Feghali MN, Catov JM, Zantow E, Mission JF, Caritis SN, Scifres CM. Timing of gestational weight gain and adverse perinatal outcomes in overweight and obese women. Obstetrics and Gynecology. 2019 May; 133(5):962-970.


Pierce SL, Zantow EW, Philips SD, Williams M. Methamphetamine-Associated Cardiomyopathy in Pregnancy: A Case Series. Mayo Clinic Proceedings. 2019 Mar; 94(3):551-554.

Frolova AI, Babb SA, Zantow E, Hagemann AR, Powell MA, Thaker PH, Gao F, Mutch DG. Impact of immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing. Gynecol Oncol. 2015 Apr; 137(1):7-13.